Click here to for more on Fess Parker's DoubleTree Resort.

Click here to for more on the Spirit of Small Business Awards Luncheon

Columns

Harbor Freight battle is a father-son feud for the ages

During the past 15 years, a tool and hardware distributor in Camarillo called Central Purchasing exploded into one of the largest private companies in the Tri-Counties as it exploited new sales channels online, in broadcast media and at 300 retail stores.

 
Muscle car supplier could have region’s biggest lease this year

In what may be the largest lease deal in the Tri-Counties to date this year, Dynacorn International leased 98,952 square feet of industrial space at 4030 Via Pescador in Camarillo. The seven-year lease is valued at more than $3.8 million, according to NAI Capital’s Ventura County office, which represented the lessee.

 
Home
Amgen lays off 100 Print E-mail
Written by Stephen Nellis   
Wednesday, 22 July 2009

Thousand Oaks-based Amgen laid off about 100 employees on July 22, the company confirmed to the Business Times.

The most recent round of cuts was among the company’s clinical manufacturing and quality-control workers. Previously, on May 1, Amgen laid off about 100 workers as part of an outsourcing of the company’s facilities services group, said Amgen spokeswoman Sarah Rockwell.

Amgen has steadily reduced its workforce since hundreds of layoffs were announced in the summer of 2007. The most recent cuts are part of the company’s “ongoing evaluation of staffing levels,” Rockwell said.

“Approximately 100 people in the United States were notified today. We are consolidating some of our clinical manufacturing and quality activities,” Rockwell told the Business Times via e-mail. “Each of the individuals notified was offered comprehensive severance benefits that include a minimum of six months salary, up to a year of company-paid health coverage and outplacement services, among other benefits.”

Amgen recently enjoyed a boost to its stock price after news that one of its experimental osteoporosis drugs beat a potential rival in a clinical study. On July 8, the stock gained about 14 percent, the biggest one-day rise in four years.

Investors are hoping the drug proves to be Amgen’s next blockbuster. Two years ago, federal regulators cracked down on the labeling of some of the company’s flagship kidney drugs, and the company laid off hundreds of workers at its Thousand Oaks headquarters after revenues sagged.

Amgen’s shares dropped a fraction of a percent to $58.37 on July 22.

Are you a subscriber? If not, sign up today for a four-week FREE trial or subscribe and receive the 2009 Book of Lists free with your purchase.

Comments
Add NewSearch
Have something to say? Submit a comment to this story.
Your Name: * (required)
Email: * (required but will not be published)
Your Title:
 
 
Security Image
Please input the anti-spam code that you can read in the image.

Copyright (C) 2007 Alain Georgette / Copyright (C) 2006 Frantisek Hliva. All rights reserved.

Last Updated ( Monday, 27 July 2009 )
 
< Prev   Next >

Joomla Templates by Joomlashack